XML 17 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2024 $ 22 $ 1,730,090 $ (1,012,542) $ (4,297) $ 6,258 $ 719,531
Beginning balance (in shares) at Dec. 31, 2024 223,456,994          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   222       222
Issuance of common stock (in shares) 506,632          
Repurchase of common stock   (391)       (391)
Repurchase of common stock (in shares) (227,495)          
Shares withheld related to net share settlement   (498)       (498)
Stock-based compensation   1,777       1,777
Stock-based sales incentive charges   17,338       17,338
Issuance of common stock warrants   2       2
Net loss     (134,967)   (64) (135,031)
Other comprehensive income (loss)       (52) 0 (52)
Ending balance at Mar. 31, 2025 $ 22 1,748,540 (1,147,509) (4,349) 6,194 602,898
Ending balance (in shares) at Mar. 31, 2025 223,736,131          
Beginning balance at Dec. 31, 2025 $ 22 1,796,957 (1,234,566) (2,992) 5,646 $ 565,067
Beginning balance (in shares) at Dec. 31, 2025 219,331,992         219,331,992
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock $ 0 165       $ 165
Issuance of common stock (in shares) 892,642          
Shares withheld related to net share settlement   (1,210)       (1,210)
Stock-based compensation   2,030       2,030
Stock-based sales incentive charges   10,107       10,107
Issuance of common stock warrants   4       4
Net loss     (12,412)   (115) (12,527)
Other comprehensive income (loss)       37 0 37
Ending balance at Mar. 31, 2026 $ 22 $ 1,808,053 $ (1,246,978) $ (2,955) $ 5,531 $ 563,673
Ending balance (in shares) at Mar. 31, 2026 220,224,634         220,224,634